Shenzhen JYMed Technology Co.,Ltd is a high-tech enterprise engaged in research and development, manufacturing and commercialization of peptides based products including active pharmaceutical ingredient peptides, cosmetic peptides, and custom peptides as well as new peptide drug development. JYMed has two wholly-owned subsidiaries: Shenzhen JYBio Pharmaceutical Co., Ltd and Hubei JY Pharmaceutical Co., Ltd, which is under construction.
JYMed's R&D center, located in Shenzhen, is set up for the research and development of new drug substances, peptide APIs and relevant products. The center is equipped with modern peptide synthesizer, large-capacity preparative purification system, and comprehensive analytical instruments including MS, HPLC, GC, UV, IC etc. The R&D center also provides technology support for both new drug discovery and manufacturing process transferring.
JYMed has four peptide API production lines in Nanjing in accordance with FDA cGMP compliance, and two finished dose biological production lines are in Shenzhen that can provide commercial batches of peptide injectables small capacity injectables and freeze-dried powder products under cGMP guidelines. In addition, we are building up sixteen production lines for peptide API in Xianning, Hubei province, China, which will be one of biggest peptide API manufacturing base in China.
JYMed has complete and efficient peptide industrialization system, can provide Comprehensive peptide service, including CRO/CMO/CDMO/OEM and Regulatory affairs support. To be Your reliable, independent and reactive supplier for your peptides!
Key Figures of JYMed
● 315 employees nationwide
● 2 RD laboratories (Pingshan, Nanshan)
● 3 manufacturing facilities
● APIs, Nanjing Lishui, JiangSu, 4 production lines in compliance with FDA
● APIs, Xian’ning, HuBei, 16 production lines in compliance with FDA（under construction）
● Finished products, 2 dosage lines in Shenzhen Pingshan, GuangDong
● 7 products submitted ANDA to CFDA, 5 products under filing
● 1 product submitted IND to CFDA
● 1 product submitted VMF (US-FDA) and obtained CEP certificate